ResearcherTongji UniversityNo recent work listed

Jiao Li

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0003-4200-5339; OpenAlex author ID A5011701828. Sources: OpenAlex.

Their work

Papers: 1
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 5

Papers, trials and grants by year

2022: 1 paper

Papers 1

HOXA10 promote pancreatic cancer progression via directly activating canonical NF-κB signaling pathway. Co-author DOI 10.1093/carcin/bgac042 ↗

Closest collaborators

The 5 strongest of 5 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Xiaohua Jiang · 1 shared paper, 2022 · strength 0.16
- Paper HOXA10 promote pancreatic cancer progression via directly activating canonical NF-κB signaling pathway. DOI 10.1093/carcin/bgac042 ↗
Yongwei Sun · 1 shared paper, 2022 · strength 0.16
- Paper HOXA10 promote pancreatic cancer progression via directly activating canonical NF-κB signaling pathway. DOI 10.1093/carcin/bgac042 ↗
Minwei Yang · 1 shared paper, 2022 · strength 0.16
- Paper HOXA10 promote pancreatic cancer progression via directly activating canonical NF-κB signaling pathway. DOI 10.1093/carcin/bgac042 ↗
Yongsheng Jiang · 1 shared paper, 2022 · strength 0.16
- Paper HOXA10 promote pancreatic cancer progression via directly activating canonical NF-κB signaling pathway. DOI 10.1093/carcin/bgac042 ↗
Junfeng Zhang · 1 shared paper, 2022 · strength 0.16
- Paper HOXA10 promote pancreatic cancer progression via directly activating canonical NF-κB signaling pathway. DOI 10.1093/carcin/bgac042 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.